Authors: Boulle, N Baudin, E Gicquel, C Logie, A Bertherat, J Penfornis, A Bertagna, X Luton, JP Schlumberger, M Le Bouc, Y

Citation: N. Boulle et al., Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors, EUR J ENDOC, 144(1), 2001, pp. 29-36

Authors: Penfornis, A Zimmermann, C Boumal, D Sabbaht, A Meneveau, N Gaultier-Bourgeois, S Bassand, JP Bernard, Y

Citation: A. Penfornis et al., Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing, DIABET MED, 18(11), 2001, pp. 900-905

Authors: Benhamou, PY Oberholzer, J Toso, C Kessler, L Penfornis, A Bayle, F Thivolet, C Martin, X Ris, F Badet, L Colin, C Morel, P

Citation: Py. Benhamou et al., Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000), DIABETOLOG, 44(7), 2001, pp. 859-864

Authors: Baudin, E Pellegriti, G Bonnay, M Penfornis, A Laplanche, A Vassal, G Schlumberger, M

Citation: E. Baudin et al., Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p ' DDD)levels on the treatment of patients with adrenocortical carcinoma, CANCER, 92(6), 2001, pp. 1385-1392

Authors: Jubault, V Penfornis, A Schillo, F Hoen, B Izembart, M Timsit, J Kazatchkine, MD Gilquin, J Viard, JP

Citation: V. Jubault et al., Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients, J CLIN END, 85(11), 2000, pp. 4254-4257

Authors: Hammel, PR Vilgrain, V Terris, B Penfornis, A Sauvanet, A Correas, JM Chauveau, D Balian, A Beigelman, C O'Toole, D Bernades, P Ruszniewski, P Richard, S

Citation: Pr. Hammel et al., Pancreatic involvement in von Hippel-Lindau disease, GASTROENTY, 119(4), 2000, pp. 1087-1095